From the Uppsala Monitoring Centre: A Review of Viewpoint Part 1 and Part 2

ISSN： 0114-5916

Source： Drug Safety, Vol.28, Iss.7, 2005-01, pp. : 645-646

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expecting the Worst: A Publication from the Uppsala Monitoring Centre

Drug Safety, Vol. 33, Iss. 12, 2010-12 ,pp. : 1135-1136

Adis International

Access to resources Recommend Favorite

The Changing Landscape of Consultant Pharmacy Part 1 of 2

By Martin Caren McHenry

The Consultant Pharmacist, Vol. 30, Iss. 12, 2015-12 ,pp. : 688-693

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

2-Arylbenzimidazoles as Antiviral and Antiproliferative Agents-Part 1

Medicinal Chemistry, Vol. 4, Iss. 6, 2008-11 ,pp. : 605-615

Bentham Science Publishers

Access to resources Recommend Favorite

A Benefit-Risk Review of Systemic Haemostatic Agents: Part 1: In Major Surgery

By Fraser Ian S.

Drug Safety, Vol. 31, Iss. 3, 2008-01 ,pp. : 217-230

Adis International

Access to resources Recommend Favorite

Dishonesty in the MRCP(UK) Part 1 and Part 2 written examinations: prevention, detection and possible remediation

By Roberts Trudie Russell Andrew Radziejowska Rebecca

Clinical Medicine, Vol. 11, Iss. 3, 2011-06 ,pp. : 239-241

Royal College Of Physicians

Access to resources Recommend Favorite